• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[锂在挪威奥斯陆郡和松恩-菲尤拉讷郡的使用情况]

[Use of lithium in the Norwegian counties Oslo and Sogn og Fjordane].

作者信息

Bramness Jørgen G

机构信息

Avdeling for legemiddelepidemiologi, Nasjonalt folkehelseinstitutt, Postboks 4404 Nydalen, 0881 Oslo.

出版信息

Tidsskr Nor Laegeforen. 2009 Apr 30;129(9):855-7. doi: 10.4045/tidsskr.08.0276.

DOI:10.4045/tidsskr.08.0276
PMID:19415083
Abstract

BACKGROUND

The Norwegian prescription database (NorPD) provides an opportunity to examine lithium consumption at an individual level. This article presents an assessment of lithium use (based on data from NorPD) in light of two population-based studies on prevalence of psychiatric illness in the counties Oslo and Sogn og Fjordane.

MATERIAL AND METHOD

All persons between 18 and 65 years who received at least one prescription for lithium between July 2005 and June 2006 were identified in NorPD. County and gender specific prevalence rates, incidence rates, and average dose were calculated. Some pharmacoepidemiological parameters were derived.

RESULTS

The incidence of lithium users was 1.5 per 1000 inhabitants in Oslo and 5.5 in Sogn og Fjordane in the period assessed. The incidence was highest for men in Sogn og Fjordane. More lithium was prescribed to each patient in Oslo than in Sogn og Fjordane, and more was prescribed for men than women.

INTERPRETATION

Patients with bipolar disease are apparently much more likely to be treated with lithium in Sogn og Fjordane than in Oslo. Previous estimates of the prevalence of bipolar disorder in Sogn og Fjordane are probably too low. In addition, there might be a broader indication for the use of lithium in this county.

摘要

背景

挪威处方数据库(NorPD)为在个体层面研究锂的使用情况提供了契机。本文根据两项基于奥斯陆郡和松恩-菲尤拉讷郡精神病患病率的人群研究,对锂的使用情况(基于NorPD数据)进行了评估。

材料与方法

在NorPD中确定了2005年7月至2006年6月期间所有18至65岁且至少接受过一次锂处方的人。计算了郡和性别特异性患病率、发病率以及平均剂量。得出了一些药物流行病学参数。

结果

在所评估的时期内,奥斯陆郡锂使用者的发病率为每1000名居民中有1.5人,松恩-菲尤拉讷郡为5.5人。松恩-菲尤拉讷郡男性的发病率最高。奥斯陆郡每位患者的锂处方量比松恩-菲尤拉讷郡多,且男性的处方量多于女性。

解读

与奥斯陆郡相比,松恩-菲尤拉讷郡的双相情感障碍患者显然更有可能接受锂治疗。此前对松恩-菲尤拉讷郡双相情感障碍患病率的估计可能过低。此外,该郡可能对锂的使用有更广泛的指征。

相似文献

1
[Use of lithium in the Norwegian counties Oslo and Sogn og Fjordane].[锂在挪威奥斯陆郡和松恩-菲尤拉讷郡的使用情况]
Tidsskr Nor Laegeforen. 2009 Apr 30;129(9):855-7. doi: 10.4045/tidsskr.08.0276.
2
Use of lithium in the adult populations of Denmark, Norway and Sweden.锂在丹麦、挪威和瑞典成年人群中的使用情况。
J Affect Disord. 2009 Nov;118(1-3):224-8. doi: 10.1016/j.jad.2009.01.024. Epub 2009 Feb 26.
3
[Cardiovascular risk factors in Oslo, Sogn and Fjordane and Finnmark. Study of 40-year old subjects in Oslo 1981-88].[奥斯陆、松恩和峡湾地区以及芬马克郡的心血管危险因素。1981 - 1988年对奥斯陆40岁人群的研究]
Tidsskr Nor Laegeforen. 1998 Jan 10;118(1):18-22.
4
The use of lithium, valproate or lamotrigine for psychiatric conditions in children and adolescents in Norway 2004-2007 - a prescription database study.2004 - 2007年挪威儿童和青少年使用锂盐、丙戊酸盐或拉莫三嗪治疗精神疾病——一项处方数据库研究
J Affect Disord. 2009 Oct;117(3):208-11. doi: 10.1016/j.jad.2009.01.006. Epub 2009 Feb 3.
5
[How many and who are receiving medication for diabetes mellitus?].[有多少人以及哪些人正在接受糖尿病药物治疗?]
Tidsskr Nor Laegeforen. 2006 Mar 9;126(6):768-70.
6
An increased risk of road traffic accidents after prescriptions of lithium or valproate?开具锂盐或丙戊酸盐处方后道路交通事故风险增加?
Pharmacoepidemiol Drug Saf. 2009 Jun;18(6):492-6. doi: 10.1002/pds.1740.
7
[Estimate of type I bipolar disorder prevalence (1996-1998)].
Rev Esp Salud Publica. 2000 Mar-Apr;74(2):131-8.
8
Changes in outpatient lithium treatment in the Netherlands during 1996-2005.1996年至2005年期间荷兰门诊锂治疗的变化。
J Affect Disord. 2008 Nov;111(1):94-9. doi: 10.1016/j.jad.2008.01.019. Epub 2008 Mar 14.
9
Trends in lithium prescription in Spain from 1985 to 2003.
J Affect Disord. 2006 Apr;91(2-3):273-6. doi: 10.1016/j.jad.2006.01.005. Epub 2006 Feb 17.
10
[Pharmacotherapeutic trends at the beginning of the millennium in Hungary: pharmacotherapy of bipolar patients. Part II].
Neuropsychopharmacol Hung. 2004 Oct;6(3):112-20.

引用本文的文献

1
Evidence of lithium underuse in bipolar disorder: analysis of lithium and antipsychotic consumption, prediction of future trends, regional disparities and indicators of rational and inappropriate use in Europe.双相情感障碍中锂盐使用不足的证据:欧洲锂盐和抗精神病药物消费分析、未来趋势预测、地区差异以及合理与不合理使用指标
Naunyn Schmiedebergs Arch Pharmacol. 2025 Jun 28. doi: 10.1007/s00210-025-04389-0.